UNSPSC 51111734: Butantrone

This classification denotes an anthraquinone compound with the molecular formula C18H16O4, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 9P148IBA8M, chemically known as 10-butyryl-1,8-dihydroxyanthrone but generally known as butantrone, which bears US NIH Compound Identifier 53271. European Medicines Agency schedules Butantrone in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06006MIG.

UNSPSC 51111734 Butantrone (Commodity) shows minimal recent state and local procurement activity aligned with the code's nominal pharmaceutical scope. The two most recent opportunities tagged to this code are actually unrelated to butantrone: one is a completed Illinois Department of Public Health piggyback award to Chartwell Rx LLC for Doxycycline Hyclate and Ciprofloxacin Hydrochloride tablets (posted August 28, 2026, $2,999,999.11 over three years), and the other is a Seminole County, Florida IFB for naloxone and drug deactivation systems (posted June 30, 2026). Neither solicitation involves butantrone or closely related pharmaceutical products, indicating the code may carry misclassified or historical activity rather than active current demand for the specific product.

The geographic activity present is limited to Florida and Illinois, with no pattern of repeat issuing bodies or established demand signals. The Seminole County procurement required quarterly deliveries and specified E-Verify and drug-free workplace compliance, typical of county health and public-safety procurement, but the mismatch between the code's named product and the actual goods being solicited suggests this code may not be a reliable source of opportunities for butantrone suppliers. Firms targeting this UNSPSC code should verify classification accuracy with prospective buyers directly, as the recent opportunities indicate either miscoding or dormant procurement activity under the code's stated commodity definition.